BACKGROUND: The number of long-term colorectal cancer survivors is increasing. Cancer and its treatment can cause physical and psychological complications, but little is known about how it impacts quality of life (QOL) over the long term-5, 10, and 15 years after diagnosis. METHODS: Cancer survivors were randomly selected from three tumor registries in France, diagnosed in 1990 (±1 year), 1995 (±1 year), and 2000 (±1 year). Controls were randomly selected from electoral rolls, stratifying on gender, age group, and residence area. Participants completed two QOL questionnaires, a fatigue questionnaire, an anxiety questionnaire, and a life conditions questionnaire. An analysis of variance was used to compare QOL scores of cancer survivors by period of diagnosis (5, 10, and 15 years) with those of controls, adjusted for sociodemographic data and comorbidities. RESULTS: We included 344 colon cancer and 198 rectal cancer survivors and 1,181 controls. In a global analysis, survivors reported a statistically and clinically significant lower score in social functioning 5 years after diagnosis and higher scores in diarrhea symptoms 5 and 10 years after diagnosis. In subgroup analyses, rectal cancer affected QOL in the physical dimensions at 5 years and in the fatigue dimensions at 5 and 10 years. CONCLUSION: Survivors of colorectal cancer may experience the effects of cancer and its treatment up to 10 years after diagnosis, particularly for rectal cancer. Clinicians, psychologists, and social workers must pay special attention to rectal cancer survivors to improve overall management.
BACKGROUND: The number of long-term colorectal cancer survivors is increasing. Cancer and its treatment can cause physical and psychological complications, but little is known about how it impacts quality of life (QOL) over the long term-5, 10, and 15 years after diagnosis. METHODS:Cancer survivors were randomly selected from three tumor registries in France, diagnosed in 1990 (±1 year), 1995 (±1 year), and 2000 (±1 year). Controls were randomly selected from electoral rolls, stratifying on gender, age group, and residence area. Participants completed two QOL questionnaires, a fatigue questionnaire, an anxiety questionnaire, and a life conditions questionnaire. An analysis of variance was used to compare QOL scores of cancer survivors by period of diagnosis (5, 10, and 15 years) with those of controls, adjusted for sociodemographic data and comorbidities. RESULTS: We included 344 colon cancer and 198 rectal cancer survivors and 1,181 controls. In a global analysis, survivors reported a statistically and clinically significant lower score in social functioning 5 years after diagnosis and higher scores in diarrhea symptoms 5 and 10 years after diagnosis. In subgroup analyses, rectal cancer affected QOL in the physical dimensions at 5 years and in the fatigue dimensions at 5 and 10 years. CONCLUSION: Survivors of colorectal cancer may experience the effects of cancer and its treatment up to 10 years after diagnosis, particularly for rectal cancer. Clinicians, psychologists, and social workers must pay special attention to rectal cancer survivors to improve overall management.
Authors: Elizabeth G Eakin; Danny R Youlden; Peter D Baade; Sheleigh P Lawler; Marina M Reeves; Jane S Heyworth; Lin Fritschi Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: Liyan Liu; Lisa J Herrinton; Mark C Hornbrook; Christopher S Wendel; Marcia Grant; Robert S Krouse Journal: Dis Colon Rectum Date: 2010-02 Impact factor: 4.585
Authors: A Belot; P Grosclaude; N Bossard; E Jougla; E Benhamou; P Delafosse; A-V Guizard; F Molinié; A Danzon; S Bara; A-M Bouvier; B Trétarre; F Binder-Foucard; M Colonna; L Daubisse; G Hédelin; G Launoy; N Le Stang; M Maynadié; A Monnereau; X Troussard; J Faivre; A Collignon; I Janoray; P Arveux; A Buemi; N Raverdy; C Schvartz; M Bovet; L Chérié-Challine; J Estève; L Remontet; M Velten Journal: Rev Epidemiol Sante Publique Date: 2008-06-10 Impact factor: 1.019
Authors: Kathleen J Yost; Elizabeth A Hahn; Alan M Zaslavsky; John Z Ayanian; Dee W West Journal: Health Qual Life Outcomes Date: 2008-08-25 Impact factor: 3.186
Authors: Catherine E Mosher; Joseph G Winger; Barbara A Given; Paul R Helft; Bert H O'Neil Journal: Psychooncology Date: 2015-08-27 Impact factor: 3.894
Authors: Michael Jefford; Karla Gough; Allison Drosdowsky; Lahiru Russell; Sanchia Aranda; Phyllis Butow; Jo Phipps-Nelson; Jane Young; Mei Krishnasamy; Anna Ugalde; Dorothy King; Andrew Strickland; Michael Franco; Robert Blum; Catherine Johnson; Vinod Ganju; Jeremy Shapiro; Geoffrey Chong; Julie Charlton; Andrew Haydon; Penelope Schofield Journal: Oncologist Date: 2016-06-15
Authors: Olga Husson; Floortje Mols; Lonneke van de Poll-Franse; Jolanda de Vries; Goof Schep; Melissa S Y Thong Journal: Support Care Cancer Date: 2015-01-06 Impact factor: 3.603
Authors: Virginia Sun; Marcia Grant; Carmit K McMullen; Andrea Altschuler; M Jane Mohler; Mark C Hornbrook; Lisa J Herrinton; Carol M Baldwin; Robert S Krouse Journal: J Wound Ostomy Continence Nurs Date: 2013 Jan-Feb Impact factor: 1.741
Authors: Melissa S Y Thong; Floortje Mols; Xin S Wang; Valery E P P Lemmens; Tineke J Smilde; Lonneke V van de Poll-Franse Journal: Eur J Cancer Date: 2013-03-01 Impact factor: 9.162
Authors: Katrina R Ellis; Mary R Janevic; Trace Kershaw; Cleopatra H Caldwell; Nancy K Janz; Laurel Northouse Journal: Psychooncology Date: 2016-05-05 Impact factor: 3.894
Authors: Talya Salz; Shrujal S Baxi; Victoria S Blinder; Elena B Elkin; Margaret M Kemeny; Mary S McCabe; Chaya S Moskowitz; Erin E Onstad; Leonard B Saltz; Larissa K F Temple; Kevin C Oeffinger Journal: J Oncol Pract Date: 2014-06-03 Impact factor: 3.840